Format

Send to

Choose Destination
Cancer. 2006 Feb 1;106(3):483-93.

CpG island hypermethylation in progression of esophageal and gastric cancer.

Author information

1
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. fsato@som.umaryland.edu

Erratum in

  • Cancer. 2006 Apr 1;106(7):1641.

Abstract

The upper gastrointestinal (GI) cancers have various carcinogenic pathways and precursor lesions, such as dysplasia for esophageal squamous cell carcinoma, Barrett esophagus for esophageal adenocarcinoma, and intestinal metaplasia for the intestinal-type of gastric cancer. Recently, many epigenetic events in carcinogenic pathways have been revealed, along with genomic and genetic alterations. This information has provided deeper insight into an understanding of the mechanisms of upper GI carcinogenesis. Moreover, detection methods of aberrant methylation have been applied to clinical fields to stratify high-risk groups, detect early cancer, and to predict clinical outcomes. In this review, a variety of information is summarized regarding gene hypermethylation in esophageal and gastric cancer.

PMID:
16362978
DOI:
10.1002/cncr.21657
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center